These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 6246423)

  • 1. Delta-9-tetrahydrocannabinol (THC) as an antiemetic.
    Zeltzer L; Barbour J; LeBaron S; Kellerman J
    N Engl J Med; 1980 Jun; 302(24):1364. PubMed ID: 6246423
    [No Abstract]   [Full Text] [Related]  

  • 2. Delta-9-tetrahydrocannabinol (THC) as an antiemetic.
    Kluin-Nelemans JC; Meuwissen OJ; Nelemans FA; Maes RA
    N Engl J Med; 1980 Jun; 302(24):1364-5. PubMed ID: 6246424
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
    Sallan SE; Cronin C; Zelen M; Zinberg NE
    N Engl J Med; 1980 Jan; 302(3):135-8. PubMed ID: 6985702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-9-tetrahydrocannabinol (THC) as an antiemetic.
    Huguley CM
    N Engl J Med; 1980 Jun; 302(24):1363-4. PubMed ID: 6246422
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.
    Steele N; Gralla RJ; Braun DW; Young CW
    Cancer Treat Rep; 1980; 64(2-3):219-24. PubMed ID: 6250699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta-9-tetrahydrocannabinol as an antiemetic.
    Anderson PO; McGuire GG
    Am J Hosp Pharm; 1981 May; 38(5):639-46. PubMed ID: 6269423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy.
    Colls BM; Ferry DG; Gray AJ; Harvey VJ; McQueen EG
    N Z Med J; 1980 Jun; 91(662):449-51. PubMed ID: 6250106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of simple somatic parameters by delta-9-trans-tetrahydrocannabinol (delta-9-THC) in a double-blind-study. Short communication.
    Zimmer BD; Bickel P; Dittrich A
    Arzneimittelforschung; 1976; 26(8):1614-6. PubMed ID: 795438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
    Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
    Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.
    Roberts JD; Gennings C; Shih M
    Eur J Pharmacol; 2006 Jan; 530(1-2):54-8. PubMed ID: 16375890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special feature: in quest of an effective antiemetic in cancer chemotherapy. Research with antiemetics for cancer chemotherapy: problems and possibilities.
    Maxwell MB
    Oncol Nurs Forum; 1982; 9(3):11-6. PubMed ID: 7050931
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol.
    Gralla RJ; Tyson LB; Bordin LA; Clark RA; Kelsen DP; Kris MG; Kalman LB; Groshen S
    Cancer Treat Rep; 1984 Jan; 68(1):163-72. PubMed ID: 6318993
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis.
    Owens NJ; Schauer AR; Nightingale CH; Golub GR; Martin RS; Williams HM; Schauer PK
    Clin Pharm; 1984; 3(2):167-70. PubMed ID: 6373102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
    Brenneisen R; Egli A; Elsohly MA; Henn V; Spiess Y
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):446-52. PubMed ID: 8897084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
    Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
    Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets.
    Van Sickle MD; Oland LD; Mackie K; Davison JS; Sharkey KA
    Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G566-76. PubMed ID: 12791597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intrapulmonary tetrahydrocannabinol administration in humans.
    Zuurman L; Roy C; Schoemaker RC; Hazekamp A; den Hartigh J; Bender JC; Verpoorte R; Pinquier JL; Cohen AF; van Gerven JM
    J Psychopharmacol; 2008 Sep; 22(7):707-16. PubMed ID: 18515447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol (Delta 9-THC) on humans.
    Carlini EA
    Toxicon; 2004 Sep; 44(4):461-7. PubMed ID: 15302527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.